SOPH Earnings

SOPH reported its earnings on 2026-03-03, showcasing a revenue of 21.71M against an estimate of 20.89M, resulting in a 3.92% surprise. The EPS was -0.28, surpassing the expected -0.2 by -40%. The stock experienced a -6.4% price change on the earnings day and a -12.6% change over the next five days, reflecting market reactions to the results.

Following SOPH's earnings announcement on 2026-03-03, the stock price moved by -6.4% on the day of the release. Over the subsequent five days, it saw a -12.6% change. Historically, SOPH's stock price tends to shift by an average of 5.25% in the 10 days leading up to earnings and -6.55% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate SOPH's annual revenue to reach 20.07M, while the EPS is projected at -0.23. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SOPH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SOPH's stock price typically moves by 5.25% in the 10 days before its earnings and -6.55% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.23 and revenue of 20.07M.

The earnings call summary and Q&A highlight strong growth prospects, including raised revenue guidance, increased customer base, and strategic investments in high ROI activities. Despite uncertainties in the pharma segment, the company shows balanced growth across sectors and a positive trend in net dollar retention. Cost optimizations and improved cash burn, along with optimistic guidance, contribute to a positive outlook. The market expansion and customer growth further support a positive sentiment, likely leading to a stock price increase in the short term.